These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6781007)

  • 1. The effect of benztropine mesylate on the prolactin response to haloperidol.
    Halbreich U; Sachar EJ; Nathan RS; Asnis GM; Halpern FS
    Psychopharmacology (Berl); 1980; 72(1):61-5. PubMed ID: 6781007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benztropine on the diurnal prolactin responses to haloperidol.
    Nathan RS; Perel JM; McCarthy T; Jarrett DB
    Psychoneuroendocrinology; 1985; 10(1):71-6. PubMed ID: 3889966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benztropine mesylate on haloperidol-induced prolactin secretion and serum haloperidol levels in rats.
    Rosenberg JM; Sideman M; Kampa IS; McGuire H; Kampa L
    J Pharm Sci; 1984 Dec; 73(12):1833-5. PubMed ID: 6527272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benztropine on haloperidol-induced prolactin secretion.
    Lal S; Mendis T; Cervantes P; Guyda H; DeRivera JL
    Neuropsychobiology; 1979; 5(6):327-31. PubMed ID: 503307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of atropine, benztropine and diphenhydramine on the reversal of haloperidol induced suppression of self-stimulation.
    Carey RJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):851-4. PubMed ID: 7178193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.
    Carey RJ; De Veaugh-Geiss J
    Psychopharmacology (Berl); 1982; 76(4):341-5. PubMed ID: 6812108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of haloperidol induced deficits in self-stimulation by anti-Parkinsonian drugs.
    Carey RJ
    Behav Brain Res; 1983 Dec; 10(2-3):405-11. PubMed ID: 6318780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 11. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
    Erzin-Waters C; Muller P; Seeman P
    Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.
    Boyer WF; Bakalar NH; Lake CR
    J Clin Psychopharmacol; 1987 Jun; 7(3):164-6. PubMed ID: 3597801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity.
    Carvey PM; Kao LC; Tanner CM; Goetz CG; Klawans HL
    Eur J Pharmacol; 1986 Jan; 120(2):193-9. PubMed ID: 3948919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine.
    Brockel BJ; Fowler SC
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1090-8. PubMed ID: 8531068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic factors in human prolactin regulation: a pituitary model for the study of a neuroendocrine system in man.
    Langer G; Sachar EJ; Nathan RS; Tabrizi MA; Perel JM; Halpern FS
    Psychopharmacology (Berl); 1979 Oct; 65(2):161-4. PubMed ID: 117485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.
    Hitri A; Craft RB; Fallon J; Sethi R; Sinha D
    Psychopharmacol Bull; 1987; 23(1):33-7. PubMed ID: 2885890
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of benztropine and haloperidol actions on rat substantia nigra dopamine cell electrophysiological activity in vivo.
    Todd CL; Grace AA
    Brain Res Bull; 1999 Jan; 48(2):219-22. PubMed ID: 10230713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benztropine-induced release of dopamine from brain in vivo.
    Goodale DB; Moore KE
    Neuropharmacology; 1975 Aug; 14(8):585-9. PubMed ID: 1178116
    [No Abstract]   [Full Text] [Related]  

  • 19. Benztropine-induced prolongation of responses to vasodilator nerve stimulation in the canine paw pad.
    Bell C
    Br J Pharmacol; 1982 Jun; 76(2):231-3. PubMed ID: 7093584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.